A clinical trial to study the effect of two drugs, Uraria rufescens and Prishnaparni (Uraria picta)in patients suffering from cough (Kasa).

Pharmacotherapeutic evaluation of Uraria rufescens (DC.) Schindl panchanga as an alternative to Prishnaparni (Uraria picta. Desv) panchanga in Kasahara Karma. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088170

Enrollment

100

Registered

2025-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical signs and symptoms of Vataja, Pittaja and Kaphaja Kasa as per diagnostic criteria. 2. Age group: 18-60 years. 3. Chronicity less than 1 month. 4. Newly diagnosed cases of Kasa. 5. Uncomplicated cases of Kasa

Exclusion criteria

Exclusion criteria: 1. Patients suffering from any known systemic disorders (like Tuberculosis, Asthma, etc.) and having Kasa as a complication of any disease will be excluded from the study. 2. Asadhya or Yapya Kasa like Kshayaja and Kshataja. 3. Other known complicated respiratory diseases have organic lesions such as tumors or any anatomical defect in the airway. 4. Uncontrolled systemic disorders like Hypertension, Diabetes Mellitus. 5. Pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Changes in scoring patterns developed for grading the clinical factors of Kasa on the 0th, 7th & 14th days.Timepoint: 14th day	—

Secondary

Measure	Time frame
1. Number of Adverse Events 2. Changes in CBC, SGPT & Serum Creatinine Timepoint: 0th day and 14th day.	—

Countries

India

Contacts

Public ContactMeghna

Institute of Teaching and Research in Ayurveda,Jamnagar, Gujarat.

brpayu@itra.edu.in7487876343

Outcome results